No filter, high-puff frequency, higher quantities of nicotine and tar in bidi The Tribune, now published from Chandigarh, ...

The most common types of lung cancer are non-small cell lung cancer (NSCLC)—which accounts for 80% to 85% of diagnosed cases of the disease in the United States—and small cell lung cancer (SCLC). Each ...

focusing on key genes linked to non-small cell lung cancer (NSCLC). Advt The study found that adenocarcinoma was the most ...

Most lung cancers are called non-small cell lung cancer (NSCLC). This group includes: adenocarcinoma squamous cell carcinoma large cell carcinoma ALK-positive lung cancer The second, smaller ...

Mumbai, Maharashtra, India Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 ... Scientists Discover That ...

A chemotherapy-free regimen of neoadjuvant nivolumab (Opdivo) with or without ipilimumab (Yervoy) induced immune activation ...

Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.

Pyxis Oncology shares dropped 40% after phase 1 data on PYX-201 for solid tumors, as one participant death raises concern.

Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...

Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC ... c-Met-positive, non-squamous NSCLC as a second ...